Can thymosin alpha 1 cause insomnia?

This site's thymosin alpha-1 citations do not report insomnia as a counted adverse event. The human findings they hold are virological response in chronic hepatitis B and 28-day mortality in sepsis, not a sleep table. Half-life on this site's profile is about 2 hours. Approved use as Zadaxin in more than 30 countries is a regulatory fact about hepatitis, not an insomnia rate this page can quote. This FAQ does not invent one.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of further names and published absences. Leftover harvested questions after the first two absence sets: more brand versus molecule names, side effects the citations did not count, compounding formulas this catalogue does not hold, national FDA and Australia fields, trial windows rather than an onset clock, named combinations with no interaction table, and oral routes that have not been studied.